FOUR SARS-COV-2 VACCINE DOSES OR HYBRID IMMUNITY IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES ON IMMUNOSUPPRESSIVE THERAPIES. A PROSPECTIVE, OBSERVATIONAL COHORT STUDY

Kristin H Bjørlykke  1     Hilde S. Ørbo  2     Anne T. Tveter  2     Trung T. Tran  3     Joseph Sexton  3     Ingrid Jyssum  3     Ingrid E. Christensen  3     Grete Kro  3     Tore K Kvien  4     Jørgen Jahnsen  4     Ludvig A. Munthe  4     Adity Chopra  4     David J. Warren  4     Gunnveig Grødeland  4     Espen A Haavardsholm  4     Siri Mjaaland  5     Sella A. Provan  5     John T. Vaage  5     Silje W. Syversen  5     Guro Lovik Goll  5     Kristin Kaasen Jørgensen  5    
1 Akershus University Hospital, Lørenskog, Norway
2 Diakonhjemmet Hospital, Oslo, Norway
3 Oslo University Hospital, Oslo, Norway
4 University of Oslo, Oslo, Norway
5 Norwegian Institute of Public Health, Oslo, Norway

Session
Late breaking abstracts III

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing